Series 01
Celebration Days
Seven Featured observances from September 2026 through June 2027, built for ERG engagement, leadership visibility, and cross-functional employee learning.
Offering 01
It is often difficult to find external speakers.
Your budget for speakers is limited.
We can help you save time and money. RxVP has an extensive network of speakers globally. All are available virtually and some in-person.
Offering 02
Twelve virtual panels, each offered across multiple time zones, designed for employees who want firsthand access to senior life sciences leaders.
Each 60-minute event features vice president-level and above speakers who provide insight into leadership journeys, market trends, and potential career paths. Every session includes 30 minutes of live Q&A to encourage audience engagement.
Based on 2025-2026 industry data, about 69% of pharmaceutical employees report being engaged and generally satisfied with their careers, with some indicators suggesting that one third of employees are not satisfied with their L&D offerings.
Series 01
Seven Featured observances from September 2026 through June 2027, built for ERG engagement, leadership visibility, and cross-functional employee learning.
Series 02
Five market-focused panels from September 2026 through February 2027, spotlighting China, India, Japan, Brazil, and Saudi Arabia.
Seven Featured observances from September 2026 through June 2027, with senior speakers curated for employee resource groups and leadership audiences.
February 2027
February 11, 2027
March 2027
May 2027
June 2027
September 15 - October 15, 2026
May 2027
September 2026 - February 2027
Panels featuring vice president-level and above speakers from key emerging markets.
Employees gain regional leadership perspective and a clearer view of the trends shaping growth markets.
Five market-focused panels spotlighting China, India, Japan, Brazil, and Saudi Arabia, regions critical to the future of life sciences.
September 2026
The world's second-largest pharmaceutical market and third-largest medical device market, with strong demand for talent and continued production growth.
October 2026
The world's fourth-largest pharmaceutical market, with continued strategic importance in the global industry.
November 2026
Projected to grow by 200%-250% by 2030, reaching $130 billion, and expected to remain a leading market for pharmaceutical employment and production.
January 2027
Growth is driven by expanded universal healthcare access through SUS, rising middle-class healthcare spending, and increased focus on rare diseases.
February 2027
Growth is driven by the Vision 2030 initiative and major healthcare privatization efforts.